The Festival of Biologics combines five conferences, theEuropean Antibody Congress, the World Immunotherapy Congress, the World Biosimilar Congress, Clinical Trials 2018 and the  HPAPI World Congress, under one roof. Our flagship conference, the European Antibody Congress first graced the stages of Lyon in 2004.

With these five events happening under one roof, our October event was fast-becoming the one stop shop for all things biologics. From early discovery through to preclinical, clinical development,manufacture, and final product, our four events have you covered. With this in mind, we have decided to combine all four world-leading conferences, and introduce to you the Festival of Biologics – the event where any biologics expert can find their place, their people and their network.

In addition to our five established congresses, we are launching a brand-new congress focusing on clinical trials for biologics,looking at why they fail, the best way to set up a trial, how to manage patient recruitment, funding trials and patient participation. With only 32% of developmental drugs making it through to phase III trials, and only 10% making it to market,it is vital that we focus on new ways to increase this success rate. Our brand new Clinical Trials Congress aims to break down the silos of clinical trial development, bringing together leading experts in the fields of clinical innovation and strategic outsourcing.

With high level, global speakers from big pharma, biotech,academia and industry, the Festival of Biologics will address the strategic and commercial aspects of discovering, developing,and bringing new biologics to patients. We bring you three days packed full of top level science, data and case studies,workshops, roundtables and networking opportunities. With 300+ speakers, 80 sponsors and exhibitors and 1000 attendees,this is not an event to be missed.